Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease.
Autor: | Oshima Y; University of Tokyo, Tokyo, Japan (Y.O.)., Hagino N; Teikyo University Medical Center, Chiba, Japan (N.H.)., Hara M; Teikyo University Hospital, Kanagawa, Japan (M.H.)., Ohfuji T; Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan (T.O.). |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of internal medicine [Ann Intern Med] 2018 Jul 17; Vol. 169 (2), pp. 133. |
DOI: | 10.7326/L18-0208 |
Databáze: | MEDLINE |
Externí odkaz: |